Mirata BioPharma's Debt Round

Mirata BioPharma raised a round of funding on May 10, 2018.

Mirata BioPharma focuses on new immuno-oncology fusion protein technology. Its initial focus is to develop biopharmaceutical compounds licensed from the research development foundation, a nonprofit su…

Articles about Mirata BioPharma's Debt Round: